Dr. Khalil Sultanem, MD
Claim this profileJewish General Hospital
Area of expertise
Head And Neck Cancers
Khalil Sultanem, MD has run 3 trials for Head and Neck Cancers. Some of their research focus areas include:
Oropharyngeal Cancer
Khalil Sultanem, MD has run 2 trials for Oropharyngeal Cancer. Some of their research focus areas include:
Affiliated Hospitals
Jewish General Hospital
The Jewish General Hospital
Clinical Trials Khalil Sultanem, MD is currently running
SABR Boost + Short-course Radiation
for Oropharyngeal Cancer
This is a randomized clinical trial comparing the outcomes of short-course chemoradiation consisting in stereotactic boost to the gross tumor and de-esclalated chemoradiation to the elective neck in human papilloma associated oropharynx cancer vs. the current standard 7-week course chemoradiation.
Recruiting
2 awards
Phase 3
9 criteria
NBTXR3 +/− Cetuximab
for Head and Neck Cancer
This is a global, open-label, randomized, 2-arm, Investigator's choice Phase 3 (Pivotal Stage) study to investigate the efficacy and safety of JNJ-90301900 (NBTXR3) / radiation therapy (RT)±cetuximab versus RT±cetuximab in treatment-naïve, platinum-ineligible, elderly participants with locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
Recruiting
2 awards
Phase 3
19 criteria
More about Khalil Sultanem, MD
Clinical Trial Related
7 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Khalil Sultanem, MD has experience with
- Cisplatin
- Radiation
- SABR Boost And De-escalated Chemoradiation
- Standard Chemoradiation
- Fluorouracil
- Gemcitabine Hydrochloride
Breakdown of trials Khalil Sultanem, MD has run
Head and Neck Cancers
Oropharyngeal Cancer
Squamous Cell Carcinoma
Human Papillomavirus
Nasopharyngeal Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Khalil Sultanem, MD specialize in?
Khalil Sultanem, MD focuses on Head and Neck Cancers and Oropharyngeal Cancer. In particular, much of their work with Head and Neck Cancers has involved p16 positive patients, or patients who are Stage I.
Is Khalil Sultanem, MD currently recruiting for clinical trials?
Yes, Khalil Sultanem, MD is currently recruiting for 2 clinical trials in Montreal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Khalil Sultanem, MD has studied deeply?
Yes, Khalil Sultanem, MD has studied treatments such as Cisplatin, Radiation, SABR boost and de-escalated chemoradiation.
What is the best way to schedule an appointment with Khalil Sultanem, MD?
Apply for one of the trials that Khalil Sultanem, MD is conducting.
What is the office address of Khalil Sultanem, MD?
The office of Khalil Sultanem, MD is located at: Jewish General Hospital, Montreal, Quebec H3T 1E2 Canada. This is the address for their practice at the Jewish General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.